Alector (ALEC) Net Cash Flow Growth (3y) (2021 - 2026)
Alector (ALEC) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -8.34% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.60% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 106.37% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 114.55% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.55% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 67.39% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 52.78% |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 35.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.64% |
| Mar 31, 2026 | -35.31% |
| Dec 31, 2025 | 29.01% |
| Sep 30, 2025 | 38.41% |
| Jun 30, 2025 | 26.50% |
| Mar 31, 2025 | -65.95% |
| Dec 31, 2024 | 72.64% |
| Sep 30, 2024 | -26.55% |
| Jun 30, 2024 | -54.19% |
| Mar 31, 2024 | -26.68% |
| Dec 31, 2023 | 7.83% |
| Sep 30, 2023 | -57.84% |
| Jun 30, 2023 | 2.23% |
| Mar 31, 2023 | -16.68% |
| Dec 31, 2022 | -136.42% |
| Sep 30, 2022 | -12.34% |
| Jun 30, 2022 | -230.83% |
| Mar 31, 2022 | 209.97% |
| Dec 31, 2021 | -115.18% |
| Sep 30, 2021 | 287.23% |